Hyloris Pharmaceuticals SA banner

Hyloris Pharmaceuticals SA
LSE:0AB6

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
LSE:0AB6
Watchlist
Price: 6.74 EUR -3.44% Market Closed
Market Cap: €1.8m

Intrinsic Value

0AB6 doesn't have a meaningful market cap.

The intrinsic value of one 0AB6 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 6.74 EUR, Hyloris Pharmaceuticals SA is hidden .

0AB6 Intrinsic Value
HIDDEN
Show

Valuation History
Hyloris Pharmaceuticals SA

Intrinsic Value History
Dive into the past to invest in the future

0AB6 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 0AB6 is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about 0AB6?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0AB6 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hyloris Pharmaceuticals SA.

Explain Valuation
Alternatives to 0AB6

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Hyloris Pharmaceuticals SA

Wall St
Price Targets

Dividends

Hyloris Pharmaceuticals SA
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

What is the Intrinsic Value of one 0AB6 stock?

The intrinsic value of one 0AB6 stock under the Base Case scenario is hidden EUR.

Is 0AB6 stock undervalued or overvalued?

Compared to the current market price of 6.74 EUR, Hyloris Pharmaceuticals SA is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett